author-photo

Ioannis A. Avramis

University of Southern California

14

Papers

464

Citations

Citation Trend

Filter By

Papers (10) Sort By

Journal Conference Others

Vascular endothelial growth factor (VEGF-A) serum levels in standard risk ALL pediatric patients (CCG-1962 study)

2016 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
Pharmacodynamic relationships between asparagine INPUT (Imax) post asparaginase (ASNase) therapy and outcome in SR ALL patients (CCG-1962)

2016 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Adverse Reactions to PEG and Erwinia Asparaginase and Correlation with Anti-Asparaginase Antibody Data and Survival in Children with Acute Lymphoblastic Leukemia (ALL): A Report From the Children9s Oncology Group Study CCG 1961.

2009 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Pharmacokinetics and Pharmacodynamics of Three Asparaginases in Pediatric Patients with Higher Risk Acute Lymphoblastic Leukemia: A Report from CCG-1961.

2004 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Deamination of Glutamine is a Prerequisite for Optimal Asparagine Deamination by Asparaginases In Vivo (CCG-1961)

2004 Anticancer Research
Show All
- Source
- Cite
- Save
Citations (66)
Changes of Amino Acid Serum Levels in Pediatric Patients with Higher-risk Acute Lymphoblastic Leukemia (CCG-1961)

2004 in Vivo
Show All
- Source
- Cite
- Save
Citations (37)
Asparaginase antibody and asparaginase activity in children with higher-risk acute lymphoblastic leukemia: Children's Cancer Group Study CCG-1961.

2004 Journal of Pediatric Hematology Oncology
Show All
- Source
- Cite
- Save
Citations (185)
In vitro and in vivo evaluations of the tyrosine kinase inhibitor NSC 680410 against human leukemia and glioblastoma cell lines

2002 Cancer Chemotherapy and Pharmacology
Show All
- Source
- Cite
- Save
Citations (33)
Taxotere and vincristine inhibit the secretion of the angiogenesis inducing vascular endothelial growth factor (VEGF) by wild-type and drug-resistant human leukemia T-cell lines.

2001 Anticancer Research
Show All
- Source
- Cite
- Save
Citations (60)
Synergistic antiviral effect of PEG-asparaginase (ONCASPAR), with protease inhibitor alone and in combination with RT inhibitors against HIV-1 infected T-cells: a model of HIV-1-induced T-cell lymphoma.

2001 in Vivo
Show All
- Source
- Cite
- Save
Citations (6)